Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Live Cells Detect Food-Borne Pathogens, Toxins

By Labmedica staff writers
Posted on 11 Mar 2008
A new technology can simultaneously screen thousands of samples of food or water for several dangerous food-borne pathogens in one to two hours. More...
The technique also can estimate the amount of microbes present and whether they pose an active health risk. This could help neutralize potential threats and improve food-processing techniques.

The technology utilizes live mammalian cells that release a measurable amount of a signaling chemical when harmed. Optical equipment and computer software then analyze this quantity to estimate the amount of harmful microbes present. The technology can recognize very small amounts of Listeria monocytogenes; a bacterium that kills one in five infected, and is the leading cause of food-borne illness. It also recognizes several species of Bacillus, a non-fatal but common cause of food poisoning.

The cells are suspended in collagen gel, a substance that captures particles of a desired size, and put into small wells within multiwell plates. Each well can test one sample, so tests can be expanded to quickly analyze as many samples as desired. Because the technology tests for bacteria and toxins that attack cell membranes, cells are used with high amounts of alkaline phosphatase, the signaling chemical released upon damage to the cell membrane.

Samples of food and water are added to biosensor wells before being incubated for one to two hours. To each well a chemical is added that reacts with the biosensor's alkaline phosphatase, yielding a yellow product that is quantified by a special camera and a computer.

Actively harmful pathogens are identified whereas those that are inactive or harmless are ignored. Other tests lack this capability, making them prone to false alarms and entailing a relatively lengthy incubation period to culture any living microbes. The new technology's discerning power also could help optimize processes to kill harmful microbes or deactivate toxins.

The technique is versatile, and the multiwell plates and their contents of gel-suspended mammalian cells can be prepared in a central location. When desired, the plates could then be shipped to the test location, such as a food-processing plant, so that on-site analysis could take place.

The suspension of live mammalian cells within a collagen gel is unique, according to the scientists from Purdue University (West Lafayette, IN, USA) who developed the technique, which was described in the February 2008 issue of the journal Laboratory Investigation.


Related Links:
Purdue University

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.